Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hartman

Showing results (371-380 of 459) with videos related to

Pageof 46
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Parallel synthesis of N-biaryl quinolone carboxylic acids as selective M(1) positive allosteric modulatorsFeng V Yang, William D Shipe, Jaime L Bunda, et al.
Bioorganic & Medicinal Chemistry|November 15, 2011
Discovery of selective glucocorticoid receptor modulator MK-5932Christopher J Bungard, George D Hartman, Jesse J Manikowski, et al.
ACS Chemical Neuroscience|July 11, 2012
Synthesis, structure-activity relationship, and pharmacological profile of analogs of the ASIC-3 inhibitor A-317567Scott D Kuduk, Christina N Di Marco, Vera Bodmer-Narkevitch, et al.
Journal of Medicinal Chemistry|August 28, 1999
Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferaseN J Anthony, R P Gomez, M D Schaber, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Non-peptide alpha(v)beta(3) antagonists. Part 5: identification of potent RGD mimetics incorporating 2-aryl beta-amino acids as aspartic acid replacementsKaren M Brashear, Cecilia A Hunt, Brian T Kucer, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
MK-7622: A First-in-Class M<sub>1</sub> Positive Allosteric Modulator Development CandidateDouglas C Beshore, Christina N Di Marco, Ronald K Chang, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptorsM S Egbertson, B Bednar, B C Askew, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolaseAntonella Converso, Timothy Hartingh, Mark E Fraley, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG bindingMark E Fraley, Kenneth L Arrington, Carolyn A Buser, et al.
Pageof 46

Showing results (371-380 of 459) with videos related to

Sort By:
Pageof 46
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Parallel synthesis of N-biaryl quinolone carboxylic acids as selective M(1) positive allosteric modulatorsFeng V Yang, William D Shipe, Jaime L Bunda, et al.
Bioorganic & Medicinal Chemistry|November 15, 2011
Discovery of selective glucocorticoid receptor modulator MK-5932Christopher J Bungard, George D Hartman, Jesse J Manikowski, et al.
ACS Chemical Neuroscience|July 11, 2012
Synthesis, structure-activity relationship, and pharmacological profile of analogs of the ASIC-3 inhibitor A-317567Scott D Kuduk, Christina N Di Marco, Vera Bodmer-Narkevitch, et al.
Journal of Medicinal Chemistry|August 28, 1999
Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferaseN J Anthony, R P Gomez, M D Schaber, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Non-peptide alpha(v)beta(3) antagonists. Part 5: identification of potent RGD mimetics incorporating 2-aryl beta-amino acids as aspartic acid replacementsKaren M Brashear, Cecilia A Hunt, Brian T Kucer, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
MK-7622: A First-in-Class M<sub>1</sub> Positive Allosteric Modulator Development CandidateDouglas C Beshore, Christina N Di Marco, Ronald K Chang, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptorsM S Egbertson, B Bednar, B C Askew, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolaseAntonella Converso, Timothy Hartingh, Mark E Fraley, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG bindingMark E Fraley, Kenneth L Arrington, Carolyn A Buser, et al.
Pageof 46